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DOI 10.1186/s12915-015-0153-1RESEARCH ARTICLE Open AccessMesenchymal adenomatous polyposis coli
plays critical and diverse roles in regulating
lung development
Yongfeng Luo1,2, Elie El Agha3, Gianluca Turcatel1,2, Hui Chen1, Joanne Chiu1, David Warburton1,2,
Saverio Bellusci3,4, Bang-Ping Qian5, Douglas B. Menke6 and Wei Shi1,2*Abstract
Background: Adenomatous polyposis coli (Apc) is a tumor suppressor that inhibits Wnt/Ctnnb1. Mutations of Apc
will not only lead to familial adenomatous polyposis with associated epithelial lesions, but will also cause aggressive
fibromatosis in mesenchymal cells. However, the roles of Apc in regulating mesenchymal cell biology and
organogenesis during development are unknown.
Results: We have specifically deleted the Apc gene in lung mesenchymal cells during early lung development in
mice. Loss of Apc function resulted in immediate mesenchymal cell hyperproliferation through abnormal activation
of Wnt/Ctnnb1, followed by a subsequent inhibition of cell proliferation due to cell cycle arrest at G0/G1, which
was caused by a mechanism independent of Wnt/Ctnnb1. Meanwhile, abrogation of Apc also disrupted lung
mesenchymal cell differentiation, including decreased airway and vascular smooth muscle cells, the presence of
Sox9-positive mesenchymal cells in the peripheral lung, and excessive versican production. Moreover, lung epithelial
branching morphogenesis was drastically inhibited due to disrupted Bmp4-Fgf10 morphogen production and
regulation in surrounding lung mesenchyme. Lastly, lung mesenchyme-specific Apc conditional knockout also
resulted in altered lung vasculogenesis and disrupted pulmonary vascular continuity through a paracrine
mechanism, leading to massive pulmonary hemorrhage and lethality at mid-gestation when the pulmonary
circulation should have started.
Conclusions: Our study suggests that Apc in lung mesenchyme plays central roles in coordinating the proper
development of several quite different cellular compartments including lung epithelial branching and pulmonary
vascular circulation during lung organogenesis.
Keywords: Adenomatous polyposis coli, Lung branching morphogenesis, Lung development, Pulmonary circulation,
Lung mesenchyme, Lung vasculogenesis, Versican, Ctnnb1Background
Lung development is a complex process, controlled by
reciprocal interactions between mesenchymal and epi-
thelial cells [1]. In mice, the primary lung epithelial buds
undergo reiterated elongation and division from E10.5, a
process called branching morphogenesis, to form a tree-
like airway structure with coordinated differentiation of* Correspondence: wshi@chla.usc.edu
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creativecommons.org/publicdomain/zero/1.0/epithelial and mesenchymal cells along proximal-distal
airways. Simultaneously, pulmonary vascular networks
are formed by angiogenesis and vasculogenesis, and
are eventually connected to the heart to establish the
pulmonary circulation around E14 [2]. During lung
branching morphogenesis, mesenchymal progenitor cells
undergo active proliferation and differentiation, giving
rise to diverse cell lineages, including airway and vascu-
lar smooth muscle cells, pericytes, and stromal fibro-
blasts. These mesenchyme-derived cell lineages not
only provide a structural support for the formation of
the branched airways and the vascular networks, butle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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lial cells by generating various morphogenic signals
such as bone morphogenetic proteins (Bmps), fibro-
blast growth factors (Fgfs), and Wnts [1]. However, the
molecular and cellular mechanisms by which mesen-
chymal cells regulate early lung development are as yet
incompletely understood.
Adenomatous polyposis coli (Apc) was originally discov-
ered as a tumor suppressor gene, and loss of function mu-
tation of Apc results in colon cancer [3]. Apc is a large
protein containing multi-domains that interact with a var-
iety of proteins, including Ctnnb1 (or β-catenin)/Axin in
canonical Wnt signaling and microtubules [4]. Therefore,
Apc plays a critical role in regulating many cellular pro-
cesses, such as cell proliferation, differentiation, migration,
and chromosomal segregation. Germline mutations of Apc
will not only lead to familial adenomatous polyposis (FAP)
with associated epithelial lesions, but will also cause ag-
gressive fibromatosis (also called desmoid tumors) in mes-
enchymal cells [5]. However, the lower incidence and
benign features of desmoid tumors in patients with Apc
germline mutation suggest that Apc may regulate mesen-
chymal cell biology through a mechanism different from
that in epithelial cells.
Homozygous mutation of Apc in mice leads to early
embryonic lethality, and conditional knockout (CKO) of
Apc in a variety of cell compartments other than me-
senchyme suggests that Apc plays important roles in
development of brain cortex, skin, and thymus [6, 7].
Abrogation of Apc in lung epithelial cells was found to
disrupt differentiation of airway club cells and ciliated
cells by upregulating the Wnt/Ctnnb1 pathway [8], while
direct activation of Wnt/Ctnnb1 in mouse embryonic
lung epithelia induces cell lineage switching to intestinal
cell types [9]. Although numerous studies have focused
on Apc in ectoderm and endoderm derived cells, expres-
sion of Apc in early embryonic lung mesenchyme was
not detected [10], and therefore, the roles of Apc in de-
veloping lung mesenchymal cells have never been ex-
plored. Herein, we have specifically deleted the Apc gene
in lung mesenchymal cells during mouse lung branching
morphogenesis, and found that loss of Apc function re-
sulted in more severe and earlier phenotypes than those
seen in the lung epithelial Apc knockout, which include
arrest of lung epithelial branching morphogenesis with
condensed mesenchyme. An early rapid increase, followed
by a decrease, in cell proliferation was observed in mesen-
chymal Apc CKO lung, due to Wnt/Ctnnb1-dependent
and Wnt/Ctnnb1-independent mechanisms, respectively.
Mesenchymal cell differentiation was also disturbed in the
Apc CKO lung, such as reduced airway and vascular
smooth muscle cell generation and the presence of Sox9-
positive mesenchymal cell population in distal lung, as
well as increased proteoglycan versican (Vcan) production.Interestingly, abnormality in both epithelial branching and
endothelial network formation was also observed, which
correlated with deregulation of growth factor production
in mesenchymal cells (Bmp4, Fgf10, Igf1, and Angpt1).
Eventually, failure to establish an intact pulmonary circula-
tion in the Apc CKO mice led to massive lung hemorrhage
and fetal lethality at mid-gestation. Therefore, our study
suggests that Apc in lung mesenchyme plays central roles
in coordinating the proper development of several quite
different cellular compartments during lung organogenesis.
Results
Homozygous deletion, but not heterozygous deletion, of
Apc resulted in ectopic activation of Wnt/Ctnnb1 in
embryonic lung mesenchyme
Using a Tbx4 lung enhancer-driven Tet-On transgenic
system generated in our lab [11], we were able to induce
Cre expression specifically in mouse embryonic lung
mesenchymal cells (Fig. 1a). The Apc CKO mice were
induced during lung branching morphogenesis by ad-
ministering doxycycline (Dox) from E10.5. Deletion of
Apc exon 14 in lung tissue was verified at both genomic
DNA and mRNA levels (Fig. 1b,1c). Since Apc is a nega-
tive regulator for the Wnt/Ctnnb1 canonical pathway
[4], loss of Apc function is expected to result in abnor-
mal activation of Ctnnb1. In our homozygous Apc CKO
embryos, hyperactivation of Ctnnb1 was detected in em-
bryonic lung mesenchyme, reflected by accumulation of
non-phospho (Ser37/Thr41, also called active) Ctnnb1 at
as early as E11.5 and significantly increased expression
of Axin2 (a Ctnnb1 downstream target gene) from E12.5
(Fig. 1d–1f and Additional file 1). In contrast, staining of
Ctnnb1 in airway epithelial cells, mainly localized on ap-
ical cell membranes, was comparable between Apc CKO
and WT lungs (Fig. 1d and Additional file 1), confirming
mesenchymal specificity of altered Wnt signaling activity
due to loss of Apc function. Interestingly, like the wild-
type (WT) controls, heterozygous Apc CKO (HT) mice
did not display detectable Wnt/Ctnnb1 activation in em-
bryonic lung mesenchyme (Fig. 1d), suggesting that a
single allele of WT Apc gene is sufficient to suppress ab-
normal activation of Wnt/Ctnnb1 signaling in these
cells.
Lung mesenchyme-specific Apc conditional knockout
resulted in abnormal lung morphogenesis and fetal
lethality at mid-gestation
Abrogation of Apc in lung mesenchyme starting from
E10.5 did not affect the overall growth of the embryos/
fetuses by comparison of their body sizes among differ-
ent genotypes (Fig. 2a). However, the Apc CKO fetuses
had severe chest hemorrhages with dark blue coloration
by gross view at E14.5 (Fig. 2a), and died soon after
E15.5. In order to determine the dynamic changes of the
Fig. 1 Embryonic lung mesenchymal deletion of Apc induced ectopic activation of Wnt/Ctnnb1 signaling. a Induced Cre expression specifically in
embryonic lung mesenchyme by a Tbx4 lung enhancer-driven Tet-On system was verified in an mT-mG reporter mouse lung (Tbx4-rtTA/TetO-Cre/mT-mG)
one day after Dox administration (E10.5-E11.5). mG (green) was only expressed when upstream floxed-mT (red) was deleted by the induced Cre. b Lung
specificity of Apc gene knockout at E11.5. Fetuses with different tail DNA genotypes were listed, and the heterozygous (lane 7) and homozygous (lane 8)
deletions of floxed (fx)-exon 14 (ΔE14) were confirmed in lung tissue genomic DNAs. Leakage of Apc gene deletion in fetal lung was not detected in the
absence of Dox induction (lane 9). c Truncation of Apc mRNA transcript in Apc conditional knockout lungs was verified by RT-PCR at E11.5. d Ectopic
activation of Wnt/Ctnnb1 signaling in embryonic lung mesenchyme was detected by accumulated non-phospho (active) Ctnnb1 in both cytoplasm and
nucleus of mesenchymal cells. Epithelial airway is highlighted with dashed line. e-f Increased Wnt canonical signaling activity in lung tissue was also verified
by elevated Axin2 expression using real-time PCR (e; n = 5 in each group, *P < 0.05) and immunofluorescence staining (f)
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E11.5 to E14.5. As shown in Fig. 2b, most of the E11.5 Apc
CKO lungs had normal epithelial domain branches sur-
rounded with appropriate mesenchyme comparable to WTlittermate controls. However, one day later (E12.5), airway
branches of the Apc CKO lungs became difficult to see
under a dissecting microscope due to a thickened and con-
densed mesenchymal compartment. The Apc CKO lung
Fig. 2 Mesenchymal-specific deletion of Apc resulted in lung malformation. a Apc CKO induced from E10.5 led to thoracic hemorrhage indicated
by dashed line at E14.5. b Gross view of isolated lungs showed that the Apc CKO caused mesenchymal hyperplasia at E12.5, growth arrest at
E13.5, and massive hemorrhage at E14.5. No significant change was observed between WT and Apc heterozygous conditional knockout
(HT) lungs
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pearance similar to Apc CKO lungs at E12.5. In contrast,
WT lungs grew rapidly with many airway branches. At
E14.5, lung tissue destruction with massive hemorrhage
was detected in Apc CKO mice, explaining the lung contu-
sion observed within the whole body view (Fig. 2a). Inter-
estingly, heterozygous Apc CKO did not result in any of
the defects as described above, suggesting that one allele of
Apc in lung mesenchymal cells is sufficient for proper early
lung development, which is consistent with the unaltered
Ctnnb1 activation shown above.
The abnormal histology of the Apc CKO lung was fur-
ther analyzed in H&E-stained tissue sections (Fig. 3). Al-
though no significant difference was observed between
E11.5 WT and Apc CKO lungs, alteration of the mesen-
chymal structure in Apc CKO lungs was obvious starting
from E12.5, with circumferentially orientated and con-
densed mesenchymal cells around epithelial tubes (see
Additional file 2 for high magnification). There were
fewer airway epithelial tubes in Apc CKO lungs starting
from E12.5 (Fig. 3). At E14.5, a massive hemorrhage with
peripheral lung tissue destruction was observed in Apc
CKO fetuses (Fig. 3 and Additional file 3).
As mentioned above, Apc is a major negative regulator
for Wnt/Ctnnb1 signaling, and the abnormal lung devel-
opment in Apc CKO fetuses could be mediated by in-
creased Ctnnb1 activation, which was indeed detected in
E12.5 Apc CKO lung mesenchyme (Fig. 1). To further
determine the potential molecular mechanism, we per-
formed a rescue experiment by generating Apc CKO in
combination with heterozygous or homozygous Ctnnb1
knockout in developing lung mesenchyme. Surprisingly,
reduction of Ctnnb1 gene dosage by single allele deletion
could not rescue lung phenotypes in Apc CKO fetuses
(Apcfx/fx/Ctnnb1fx/wt/Tbx4-rtTA/TetO-Cre in Fig. 4),
while null deletion of Ctnnb1 alone (Apcwt/wt/Ctnnb1fx/fx/
Tbx4-rtTA/TetO-Cre) resulted in reduced branching mor-
phogenesis without change in mesenchymal cell density.
Furthermore, null mutation of Ctnnb1 in combination
with Apc CKO (Apcfx/fx/Ctnnb1fx/fx/Tbx4-rtTA/TetO-Cre)
resulted in complicated lung growth arrest, but no mesen-
chymal condensation (Fig. 4), suggesting that abnormal
mesenchymal condensation of early Apc CKO fetal lung
may be mediated by hyperactivation of Ctnnb1 following
Apc deletion.
Loss of Apc function in lung mesenchymal cells results in
dynamic changes in cell proliferation that eventually lead
to arrest of lung growth
Given that Apc is a negative regulator for Wnt/Ctnnb1
signaling, loss of Apc function could have an important
impact on mesenchymal cell proliferation. Short-term 5-
ethynyl-2-deoxyuridine (EdU) incorporation was used to
identify cells with active DNA synthesis. Consistentlywith activation of Wnt/Ctnnb1 signaling (Fig. 1), in-
creased 2-hour EdU labeling was detected in lung mes-
enchymal cells rather than epithelial cells at E11.5, one
day after Apc knockout induction (Fig. 5a,5b). However,
while both epithelial and mesenchymal cells in WT em-
bryonic lungs retained a steady rate of cell proliferation
shown by 2-hour EdU labeling at E12.5 and E13.5, cell
proliferation in both epithelial and mesenchymal cells of
Apc CKO lungs was then significantly reduced (Fig. 5a,5b).
Interestingly, mouse embryos with a lung mesenchyme-
specific activation of Ctnnb1 from E10.5 (Tbx4-CreERT2/
Cnntb1floxed-ex3 or Ctnnb1 Δex3/+) had a sustained in-
crease of lung mesenchymal cell proliferation, as detected
by 2-hour EdU incorporation during early lung develop-
ment (Fig. 5c,5d and Additional file 4), suggesting that
subsequent reduction of cell proliferation in Apc CKO
lungs after E12.5 is likely independent of aberrant Ctnnb1
activation.
To further understand the related mechanisms, we
performed a pulse-chase experiment with EdU labeling
at E11.5 and detection of the labeled DNA at E13.5. In
WT lung, only a few cells were still positive for early
EdU labeling due to continuous cell division and rounds
of DNA synthesis (Fig. 6a). In contrast, the majority of
lung mesenchymal cells in Apc CKO lungs were still
EdU-positive. Interestingly, the sizes of mesenchymal
cell nuclei in E13.5 Apc CKO lungs (30.0 ± 3.7 μm2)
were significantly larger than those of WT littermate
controls (23.8 ± 2.7 μm2, P < 0.05) and those of E11.5
Apc CKO lungs (23.0 ± 3.2 μm2, P < 0.05). These data
suggested that the cells with Apc deletion were subse-
quently arrested in the cell cycle. Since interaction be-
tween Apc and the plus-end of microtubules is reported
to be essential for spindle formation and chromatin segre-
gation at metaphase in cultured cells [4], cell cycle analysis
of Apc knockout lung mesenchyme was then performed in
order to provide a potential mechanism for altered cell
proliferation. Surprisingly, most Apc CKO lung mesenchy-
mal cells were negative for phosphorylated Histone 3
(PH3), a marker of metaphase. Instead, from E12.5, they
had more primary cilia as detected by acetylated α-tubulin
staining (Fig. 6b and Additional file 5A), which is a post-
mitotic cellular structure existing in G0/G1 phase [12, 13].
These findings indicate that lung mesenchymal cells with
Apc deletion are arrested at G0/G1 phase rather than me-
taphase. To further verify this, single cell suspensions pre-
pared from E13.5 lung were assessed for their DNA
contents using propidium iodide staining and fluorescence-
activated cell sorting (FACS) analysis (Fig. 6c). 83 % of Apc
CKO lung mesenchymal cells were in G0/G1 phase, a sig-
nificantly higher percentage than that in the WT controls
(63 %), while the cells at S and G2/M phases were relatively
lower in Apc CKO lung (13.9 % and 2.8 %) than those
(26.7 % and 10.2 %) in the WT controls. Therefore, the
Fig. 3 Dynamic changes of abnormal lung structure in Apc CKO lungs. There was no significant histological difference in E11.5 lungs between
WT and Apc CKO mice. Aggregative growth of mesenchymal cells in Apc CKO lungs was apparent from E12.5. Lung tissue (arrowheads) was
interspersed with massive areas of hemorrhage at E14.5
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CKO lung after E12.5 was not due to metaphase arrest,
but rather due to more cells exiting the cell cycle.
Additional studies were performed to determine the cel-
lular mechanisms underlying lung growth arrest, including
cell senescence and apoptosis. The dynamic expression of
key genes involved in the cell cycle was measured usingreal-time PCR (Fig. 6d). Interestingly, c-Myc expression was
increased at E11.5, not changed at E12.5, and decreased at
E13.5. The increased c-Myc protein expression in E11.5
Apc CKO fetal lung mesenchymal cells was also verified by
immunostaining (Additional file 5B). Moreover, the mRNA
level of Ccnd1 (encoding cyclin D1) was significantly re-
duced from E12.5 to E13.5 in Apc CKO lungs. The changes
Fig. 4 Phenotypic changes of E13.5 lungs with Apc and Ctnnb1 double conditional knockout in lung mesenchyme. Lung tissues with indicated
Apc and Ctnnb1 genotypes were shown by gross view (a) and H&E-stained tissue sections (b). All fetal lungs shown here were positive for
Tbx4-rtTA and TetO-Cre transgenes. Dox induction was started from E10.5
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tein level by western blot (Fig. 6e). However, expression or
activation of genes associated with cell senescence, Glb1
(encoding SA-β-galactosidase) and phospho-p53 [14, 15],
were not altered (Fig. 6d,e). In addition, activation of the
apoptotic pathway and number of apoptotic cells, evaluated
by caspase 3 activation and nuclear DNA fragmentation
(Fig. 6e and Additional file 6), were not changed between
Apc CKO lung and WT controls. Therefore, with apoptosis
and senescence ruled out, the impaired growth of embry-
onic lung in Apc CKO fetuses is likely due to G0/G1 cell
cycle arrest.
Apc is essential for appropriate mesenchymal cell
differentiation and some extracellular matrix production
During branching morphogenesis, mesenchymal cells
surrounding proximal airways or vasculature, marked by
epithelial Sox2 or endothelial PECAM1, differentiate
into airway or vascular smooth muscle cells. However,abrogation of Apc significantly inhibited both proximal
airway and vasculature smooth muscle cell differentiation,
as detected by α-smooth muscle actin (SMA) staining in
Fig. 7a. Interestingly, some mesenchymal cells in E13.5
peripheral lung of Apc CKO fetuses expressed Sox9, while
only peripheral airway epithelial cells in the WT lung were
positive for Sox9 staining at this stage (Fig. 7b). Although
the exact identity of these Sox9-positive mesenchymal
cells is unknown, commitment and differentiation of lung
mesenchymal cell lineages in Apc CKO lung appear to be
severely disrupted.
In addition to cellular changes, some extracellular
matrix protein production and deposition were also al-
tered in Apc CKO embryos after E12.5. One of these
was versican (Vcan), a large chondroitin sulfate proteo-
glycan. Expression of Vcan in normal embryonic lung is
restricted to a thin mesenchymal cell layer that sur-
rounds large airways after E12.5 (Fig. 8a). However, abro-
gation of Apc in embryonic lung mesenchyme induced
Fig. 5 Dynamic changes in cell proliferation of Apc CKO lung. a-b Increased DNA synthesis, measured by EdU incorporation, in mesenchymal
cells was found in lungs of Apc CKO mice at E11.5 (a-b), while decreased EdU labeling was observed in both epithelial and mesenchymal cells in
Apc CKO lungs after E12.5. c-d Increased EdU incorporation persisted to E13.5 in lung mesenchyme when constitutively active Ctnnb1 (or Ctnnb1
Δex3) was expressed in mice with genotypes of Tbx4-CreERT/Ctnnb1fx-ex3/+ plus tamoxifen induction at E10.5. a, c: Tissue immunofluorescence
staining; b, d: quantitative analyses of the immunostained cells. Ep: epithelial cells, Me: mesenchymal cells. *P < 0.05, n = 4
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Fig. 6 Cell cycle arrest at G0/G1 phase in E13.5 Apc CKO lung. a Significant reduction of cell division in E13.5 Apc CKO lung, indicated by
increased cells that retain EdU DNA labeling at E11.5. Increased nuclear size (insert) was apparent in Apc CKO lung. b Immunostaining for PH3
and acetyl-α-tubulin, markers for metaphase and G0/G1 phase, respectively. c FACS analysis of DNA contents for the cells isolated from E13.5 Apc
CKO or WT control lungs. d Expression of key genes involved in regulation of cell cycle and senescence, detected by real-time PCR. *P < 0.05,
n = 4. e Protein levels of the related genes were detected by western blot
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Fig. 7 Abrogation of Apc altered lung mesenchymal cell differentiation. a Deficient smooth muscle cell differentiation, detected by SMA
immunostaining, was observed in both proximal airways (a) and vasculature (v) of E13.5 Apc CKO lung, which were marked by positively stained
Sox2 and PECAM1, respectively. b Abnormal Sox9 expression was seen in the mesenchymal cells disseminated in peripheral lung of Apc CKO
after E12.5. Lung epithelial cells were marked by cytokeratin staining. Cell nuclei were counterstained with DAPI (blue). *Hematopoietic cells with
non-specific autofluorescence in E11.5 lungs
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Fig. 8 Hyperactivation of Wnt/Ctnnb1 pathway caused by Apc deletion in lung mesenchyme induced abnormal expression of Vcan. a Increased
Vcan protein expression and distribution were detected in Apc CKO lung after E12.5, shown by immunofluorescence staining. Cell nuclei were
counterstained with DAPI (blue). b Simultaneous deletion of Ctnnb1 in E13.5 Apc CKO lung mesenchyme blocked excessive Vcan expression.
c Two sites containing Ctnnb1 binding DNA consensus sequences, which have been reported in Ctnnb1 target gene Axin2, were identified in
Vcan promoter DNA. d Interaction between Ctnnb1 and Vcan promoter DNA was validated by ChIP using anti-active Ctnnb1 antibody.
Anti-histone H3 and normal IgG were used as positive and negative controls, respectively
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with the pattern of excessive Ctnnb1 activation. Moreover,
simultaneous abrogation of Ctnnb1 in Apc CKO lung mes-
enchyme blocked the abnormal expression of Vcan (Fig. 8b),
suggesting that hyperactivation of the Wnt/Ctnnb1 path-
way in Apc CKO lung mesenchyme is responsible for this
phenotypic change. In order to determine the related mo-
lecular mechanism, the Vcan promoter DNA sequence was
analyzed. At least two Ctnnb1/TCF consensus binding sites
(5′-CTTTGAT-3′ or 5′-ATCAAAG) were identified in the
Vcan promoter (−3197 to −3191 and −911 to −905, Fig. 8c).
To further confirm the direct binding of Ctnnb1/TCF to
the Vcan promoter, chromatin immunoprecipitation (ChIP)
using anti-Ctnnb1 antibody was performed for E18.5 nor-
mal lung tissue. As shown in Fig. 8d, both Ctnnb1/TCF
consensus binding sites mentioned above have been shown
to interact with Ctnnb1/TCF specifically, indicating that
excessive expression of Vcan is mediated by hyperacti-
vation of the Wnt/Ctnnb1 pathway due to loss of Apc
inhibitory function.
Abrogation of mesenchymal Apc function inhibited
epithelial branching morphogenesis by a paracrine
mechanism
Lung epithelial branching morphogenesis requires coordi-
nated signaling between epithelial and mesenchymal cells.Mesenchymal Apc CKO resulted in smaller lung size at
E13.5 (Fig. 2). The change in airway epithelial structure
was visualized by whole mount E-cadherin immunofluor-
escence staining (Fig. 9a). Compared to WT lungs, elong-
ation of the primary epithelial tubes and terminal bud
sprouting were drastically inhibited in the Apc CKO lungs.
In order to understand the molecular mechanisms by
which altered mesenchymal Apc/Ctnnb1 activity disrupts
epithelial branching, expression of genes encoding key
epithelial growth factors was examined. A substantial de-
crease of Fgf10 expression (>5 fold) and a striking increase
of Bmp4 expression (>20 fold) at the mRNA level were de-
tected in Apc CKO lungs as early as E11.5, before mor-
phological changes had occurred (Fig. 9b). Furthermore,
whole-mount in situ hybridization showed that Fgf10 ex-
pression domains at the distal tips of the lung bud mesen-
chyme were reduced or even absent (Fig. 9c), compared to
those in the WT controls. In contrast, pronounced Bmp4
expression was detected throughout the entire lung mes-
enchyme at E11.5, compared to the relatively restricted
pattern of Bmp4 expression to the tips of epithelial cells in
WT lung (Fig. 9c). Changes of Bmp4 and Fgf10 protein
expression in the entire lung tissue at E13.5 were also con-
firmed by western blot (Fig. 9d). Since Bmp4 expression
can be directly upregulated by Wnt/Ctnnb1 signaling in
embryonic lung mesenchyme [16], we then wondered
Fig. 9 Lung epithelial branching morphogenesis was severely impaired in Apc CKO embryos. a Lung epithelial branches at E13.5 were visualized
by whole mount E-cadherin immunofluorescence staining. b Altered expression of Fgf10 and Bmp4 in Apc CKO lung at E11.5 was detected by
real-time PCR. *P < 0.05, n = 5. c Whole mount in situ hybridization showed that Fgf10 transcript was downregulated in the mesenchymal tips of
Apc CKO lung at E11.5. In contrast, Bmp4 expression was dramatically increased in the sub-mesothelial mesenchyme of Apc CKO lung. Insert: distal
tip in the vibratome section. Scale bar: 100 μm. d Alterations of Fgf10 and Bmp4 expression in E13.5 Apc CKO lung were verified at the protein
level by western blot. e-f Treatment of cultured human fetal lung fibroblasts HLF1 with BMP4 (50–100 ng/ml) inhibited Fgf10 expression at the
mRNA level (e, measured by real-time PCR) and the protein level (f, detected by western blot). *P < 0.05, n = 5
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could be mediated by increased Bmp4. Therefore, the
regulatory effect of Bmp4 on Fgf10 gene expression in cul-
tured human fetal lung fibroblast line HLF1 was exam-
ined. High concentrations of BMP4 (50–100 ng/ml) were
able to inhibit Fgf10 expression at both mRNA and pro-
tein levels (Fig. 9e,f).
Loss of mesenchymal Apc function also disrupts lung
vasculogenesis and formation of the pulmonary
circulation by a paracrine mechanism
Massive lung hemorrhage in Apc CKO fetuses occurred
around E14.5 (Figs. 2 and 3), when the pulmonary circula-
tion should have started. This suggests that mesenchymal
Apc function is essential for regulating lung vasculogen-
esis and/or angiogenesis as well as for building intact pul-
monary circulation networks. In order to determine the
vascular continuity in Apc CKO lungs, fluorescein isothio-
cyanate (FITC)-labeled lectin, an endothelial tracer, was
injected into the right cardiac ventricle of E13.5 live fe-
tuses 5 min before lung harvest, and pulmonary vascular
perfusion was visualized by FITC-lectin binding. In
addition, all the vasculature within the same lung tissue
section was labeled by PECAM1 staining (Fig. 10a). We
found that the proximal large vessels in Apc CKO lungs
were readily perfused (Lectin+/PECAM1+), while the distal
small vessels were not (Lectin−/PECAM1+). In contrast, a
plexus-like pattern of lectin-labeled vasculature perfectly
matched the PECAM1-stained endothelial cells in the WT
lungs, indicating thorough perfusion and a well-established
pulmonary circulation at this stage. Therefore, lung mes-
enchymal Apc CKO fetuses had disrupted pulmonary cir-
culation due to disconnection between proximal vessels
and the distal vasculature, which could result in the
massive pulmonary hemorrhage and loss of blood, and
eventually fetal lethality.
To further understand these related mechanisms, we
then investigated the dynamic changes of lung vascular for-
mation from E12.5 to E14.5 in Apc CKO mice by detecting
two different endothelial cells markers: Flk1 and PECAM1.
Flk1 is present in both pre-mature and mature endothelial
cells, while PECAM1 is only expressed in mature endothe-
lial cells [17]. Thus, Flk1+/PECAM1− cells represent endo-
thelial progenitors (angioblasts) and Flk1+/PECAM1+ cells
are mature endothelial cells. At E12.5, although both WT
and Apc CKO lungs had comparable patterns of Flk1 and
PECAM1 protein immunostaining, with the majority of
cells being Flk1+/PECAM1+, Flk1 expression at the mRNA
level in Apc CKO lung was already reduced significantly
(Fig. 10b,c). One day later (E13.5), Flk1+/PECAM1− cells in
Apc CKO lung were decreased, accompanied by an overall
reduction and simplification of the peripheral vascular
network (Fig. 10c). Furthermore, by E14.5, a marked re-
duction of the entire vascular network was seen in ApcCKO lung, including reductions in both Flk1+/PECAM1+
and Flk1+/PECAM1− cells.
Studies have shown that the pulmonary circulation net-
work may be formed by two coordinated mechanisms,
proximal angiogenesis and distal vasculogenesis [2]. Our
recent study using the Tbx4-rtTA/TetO-Cre/mT-mG re-
porter mice with Dox induction from E6.5 suggests that
early lung mesenchymal progenitor cells give rise to the
endothelial progenitor cells for vascular formation [11].
However, using the same driver/reporter line, we found
that Dox induction from E10.5 did not mark both prema-
ture and mature endothelial cells with green fluorescent
protein (GFP) (Additional file 7), and therefore, deletion of
the Apc gene in our Apc CKO mice should not occur in
these endothelial cells. This was further verified by no
change of Ctnnb1 activation in Flk1+ cells of E12.5 Apc
CKO lungs induced from E10.5 (Fig. 10d). Thus, the effect
of mesenchymal Apc conditional knockout on vascular de-
velopment was indirect, possibly through a paracrine
mechanism. We then screened for changes of key growth
factors that are important in vasculogenesis. Surprisingly,
there was no difference in Vegf-a expression between WT
and Apc CKO lungs (Fig. 10e). However, expression of Igf1
and Angpt1 at the mRNA level was markedly reduced in
E12.5 Apc CKO lungs, suggesting that deregulation of
multiple growth factors may disrupt pulmonary vascular
formation in this model system.
Discussion
Although extensive studies have been performed to deter-
mine Apc functions in epithelial progenitor/stem cell biol-
ogy and tumorigenesis, the roles of Apc in mesenchymal
cells during development and tissue homeostasis have not
been fully investigated. It is known that loss of Apc func-
tion in mesenchymal progenitor cells in adults causes
desmoid tumors, as seen in patients with familial aden-
omatous polyposis. However, the role of mesenchymal
Apc in regulating tissue development and organogenesis
has not been fully investigated. Immunohistochemical re-
sults of a previous study indicated that expression of Apc
was restricted to embryonic lung epithelial cells [10], rais-
ing the question of whether lung mesenchymal Apc is
necessary during early lung branching morphogenesis.
However, by generating lung mesenchyme-specific genetic
deletion of Apc during development, our current study
suggests that Apc expression in early embryonic lung mes-
enchymal cells is in fact essential for both lung branching
morphogenesis and pulmonary circulation establishment
through a variety of mechanisms. Thus, previous failure to
detect Apc protein in early lung mesenchyme could have
resulted from low endogenous levels of Apc and/or low af-
finity of the antibody used for immunostaining detection.
Apc is a major negative regulator of Wnt signaling, as
it directly binds to Ctnnb1 and forms a multi-protein
Fig. 10 Apc knockout in lung mesenchyme disrupted pulmonary vascular network formation and pulmonary circulation continuity. a The
endothelial cells of E13.5 pulmonary vasculature that was connected to the right heart were labeled with FITC-lectin after its intracardial injection,
while all mature vascular endothelial cells were immunostained with anti-PECAM1. b Decreased expression of Flk1 at the mRNA level was
readily detected in E12.5 Apc CKO lungs, *P < 0.05, n = 5. c Dynamic changes of angioblasts (Flk1+/PECAM1−) and mature endothelial cells
(Flk1+/PECAM1+) in Apc CKO lung. Reduced angioblasts were detected in Apc CKO lung at E13.5, while both angioblasts and mature endothelial
cell numbers appeared significantly reduced in Apc CKO lung at E14.5. d Increased Ctnnb1 activation was not detected in Flk1+ cells in Apc CKO
lung. e Reduced expression of Igf1 and Angpt1 at the mRNA level was detected in Apc CKO lungs at E12.5 (*P < 0.05, n = 5)
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3, and Axin, resulting in Ctnnb1 phosphorylation and
ubiquitination-mediated degradation [18]. Therefore, ap-
propriate levels of Apc can provide a fine-tuning
for Wnt/Ctnnb1 activity. In general, hyperactivation of
Wnt/Ctnnb1 promotes cell cycle progression, resulting
in increased cell proliferation and decreased cell dif-
ferentiation [19]. For example, ectopic expression of
constitutively active Ctnnb1 in fetal lung epithelial cells
results in highly proliferative cuboidal epithelia that lack
fully differentiated lung cell types [9], while blockade of
canonical Wnt signaling in lung mesenchymal cells by
deleting Ctnnb1 causes cell arrest at G1/S and reduced
lung growth [20]. In our present study, we found that
specific abrogation of Apc in lung mesenchymal cells
caused an immediate increase in cell proliferation at
E11.5 (Fig. 5), leading to the massive expansion of mes-
enchymal cells observed in E12.5 lung (Fig. 3). This
might be attributed to activation of Wnt/Ctnnb1 signal-
ing, as shown by accumulation of non-phospho (active)
Ctnnb1 and concomitantly increased expression of its
target gene c-Myc (Fig. 6 and Additional file 5), a cell-
cycle effector that contributes to G1 progression. How-
ever, such increased cell proliferation was not sustained,
and instead, cell proliferation was then reduced by E12.5
and lung growth was then arrested (Figs. 5 and 6). Inter-
estingly, gain-of-function mutation in Ctnnb1 by delet-
ing its exon 3 in lung mesenchymal cells resulted in a
prolonged increase in cell proliferation, with no subse-
quent decrease of cell proliferation, as observed as late
as E13.5 (Fig. 5 and Additional file 4). Thus, one possi-
bility is that cell growth arrest in the Apc CKO lung is
Wnt/Ctnnb1 independent. Alternatively, deletion of the
microtubule binding domain in our Apc mutant might
suggest another potential mechanism for reduced cell
proliferation, since this domain mediates nuclear spindle
assembly and chromatin segregation during mitosis [21].
However, cells in metaphase were not increased in our
Apc CKO lungs; instead, most of the Apc CKO mesenchy-
mal cells were arrested in G0/G1 phase at E13.5 (Fig. 6).
Furthermore, expression of both Ccnd1 and c-Myc genes
in our Apc CKO lungs was significantly reduced after
E12.5 or later by an unknown mechanism. Thus, consider-
ing all these results, deletion of Apc in embryonic lung
mesenchyme appears to directly promote cell proliferation
by activating Wnt/Ctnnb1 signaling, followed by indirect
inhibition of the cell cycle at G0/G1 by downregulation of
Ccnd1 and c-Myc.
In addition to affecting cell proliferation, Apc knock-
out also disrupted lung mesenchymal cell differentiation,
in particular, airway and vascular smooth muscle cell
formation. Interestingly, Carraro et al. reported that in-
creased Apc expression accompanied by downregulation
of Wnt/Ctnnb1 activity, achieved by knocking downmiR-142-3p, promoted parabronchial smooth muscle
cell progenitor differentiation [22]. Therefore, it seems
that Apc functions as a positive regulator for airway
smooth muscle cell differentiation by inhibiting Wnt/
Ctnnb1 activity. Sox9-positive progenitor cells in normal
peripheral lung are restricted to distal epithelial cells.
Interestingly, Apc knockout resulted in Sox9-positive
mesenchymal cells disseminated in distal lung mesen-
chyme, which were negative for another chondrocyte
marker collagen II (data not included). The identity of
those Sox9-positive mesenchymal cells in peripheral
lung remains to be determined. It has been reported that
Wnt/Ctnnb1 does not regulate Sox9 expression in lung
epithelial cells, unlike in intestinal epithelial cells [23].
Considering the different patterns of Ctnnb1 activation
in all cells versus sparse Sox9-positive cells in Apc CKO
lung mesenchyme (Figs. 1 and 7), expression of Sox9
may not be due to Wnt/Ctnnb1 activation in lung mes-
enchymal cells. In addition, loss of Apc function also
causes excessive expression of Vcan, a proteoglycan core
molecule that has been shown to play a key role in regu-
lating tissue development [24]. Upregulated Vcan ex-
pression is related to Wnt/Ctnnb1-stimulated fibroblast
aggregative growth in vitro [25], and to inhibition of
neural crest migration through its anti-adhesive activity
[26]. In our study, lung mesenchymal Apc CKO led to
aberrant activation of Ctnnb1 and Vcan expression,
which may result in aggregative growth of lung mesen-
chyme and inhibition of epithelial cell migration on the
distal tips and branching in vivo. For the first time, we
also mapped Ctnnb1/TCF binding sites on a Vcan pro-
moter. Taken together, our data suggest that Apc func-
tions as a key factor to control lung mesenchymal cell
lineage commitment and differentiation possibly through
both Wnt/Ctnnb1-dependent and Wnt/Ctnnb1-inde-
pendent pathways.
In addition to affecting mesenchymal cell biology, ab-
rogation of mesenchymal Apc function also inhibited
epithelial growth by disrupting multiple evolutionarily
conserved growth factors, including Fgf and Bmps. It
has been reported that mesenchymal Fgf10 directly pro-
motes both proliferation and chemotaxis of epithelial
cells on the branching tips, accompanied by indirect in-
duction of epithelial Bmp4 expression. As a result, mes-
enchymal Fgf10 expression at the tip is then inhibited
through unknown mechanisms [27]. Now for the first
time, we have shown that a high level of BMP4 was able
to inhibit Fgf10 expression in cultured fetal lung fibro-
blasts, which is also consistent with our observation of
opposing changes in Bmp4 and Fgf10 gene expression
detected in our Apc CKO lungs (Fig. 9).
In parallel with airway development, lung vasculogen-
esis and pulmonary circulation establishment are the
other important events necessary to form a functional
Fig. 11 The postulated mechanisms of mesenchymal Apc as a
central player in early lung development. Mesenchymal Apc not
only regulates mesenchymal cell biology but also coordinates
development of other cell compartments through both Wnt/
Ctnnb1-dependent and Wnt/Ctnnb1-independent pathways
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into the lung from the hilum by angiogenic sprouting
from the dorsal aorta or aortic sac [28], whereas in the
distal lung, vasculogenesis creates a capillary bed in the
foregut mesoderm [29]. The distal and proximal compo-
nents are then fused at E13-E14 in mice to complete the
pulmonary vascular circuit. Therefore, compromised
continuity of the vasculature due to disconnection be-
tween distal and proximal vessels in the Apc CKO lungs
likely led to vascular leakage around E14 when pulmon-
ary circulation is initiated. This impaired continuity was
also confirmed by observing trypan blue dye leakage in
Apc CKO lungs after its intracardiac injection (data not
shown). This could explain why massive hemorrhage
into the thoracic cavity occurred one day later (E14.5,
Figs. 2 and 3). Interestingly, it has been reported that
blockade of Wnt ligand production from fetal lung epi-
thelial cells by deleting Wntless (or Gpr177) also results
in pulmonary hemorrhage, but such lesion occurs at a
late developmental stage (neonatal) with less severity
(interstitial capillary leakage without destruction of sac-
cular structure) [30, 31]. It appears that pulmonary
hemorrhage caused by lung mesenchymal Apc deletion
versus epithelial Wntless knockout is mediated by differ-
ent mechanisms. Vascular development is a complicated
and multistep process that includes commitment of
primitive progenitor cells to vascular progenitors [29].
By detecting dynamic changes in both angioblasts and
mature endothelial cells, we found that the Apc CKO
lung has an initially reduced population of vascular pro-
genitors, and eventually a deficiency of mature endothe-
lial cells (Fig. 10). These changes are not directly caused
by Apc deletion in the endothelial linage because the
Tbx4-rtTA driver line is not able to target the endothe-
lial cell lineage after E10.5 (Additional file 7). Instead, a
paracrine mechanism originating in affected lung mesen-
chymal cells must to be involved in this phenotypic gen-
eration. Igf1 is a potently angiogenic peptide to fetal
lung endothelial cells [32], which was reduced in our
Apc CKO lungs (Fig. 10). In addition, reduced Angpt1
expression in Apc CKO lung could be another mechan-
ism, since defects of Angpt1 or its receptor Tie2 result in
impairment of vascular network remodeling and embry-
onic death [33]. Angpt1 is also related to resistance to
vascular leakage [34]. Therefore, reduced expression of
Igf1 and Angpt1 may be an important molecular mech-
anism underlying defective vasculogenesis and discon-
nected pulmonary circulation in the Apc CKO lungs.
Conclusion
Apc in early embryonic lung mesenchymal cells plays a
critical and diverse role in regulating lung epithelial
branching morphogenesis and mesenchymal growth as
well as pulmonary vascular network formation throughboth Wnt/Ctnnb1-dependent and Wnt/Ctnnb1-inde-
pendent mechanisms (Fig. 11).
Methods
Mouse strains, breeding, and genotyping
Lung mesenchyme-specific Apc CKO mice were gener-
ated at the animal facility of Children’s Hospital Los
Angeles by crossing homozygous Apcfx/fx mice and the
triple transgenic driver line (Apcfx/wt/Tbx4-rtTA/TetO-
Cre), with Dox induction (625 mg/kg in food (TestDiet)
and 0.5 mg/ml in drinking water (Sigma)) from E10.5.
Floxed-Apc (Apcfx/fx) mice and mT-mG double fluo-
rescence Cre reporter mice were obtained from Jackson
Laboratory [7, 35]. Tbx4-rtTA was generated in our lab
[11]. The TetO-Cre mouse line was provided by Dr.
Jeffrey Whitsett at Cincinnati Children’s Hospital [36].
Mice with one of the following tail DNA genotypes:
Apcfx/fx, Apcfx/fx/Tbx4-rtTA, Apcfx/fx/TetO-Cre, Apcfx/wt,
Apcfx/wt/Tbx4-rtTA, or APCfx/wt/TetO-Cre, had no dele-
tion of Apc allele and displayed normal lung morpho-
genesis, and therefore were grouped as the “WT” control.
Cre-mediated deletion of Apc exon 14 leads to premature
termination of Apc peptide, and most functional domains
including binding sites for Ctnnb1 and microtubule were
truncated [7]. For generation of Apc/Ctnnb1 double knock-
out in lung mesenchyme, double heterozygous (Apcfx/wt/
Ctnnb1fx/wt) mice carrying Tbx4-rtTA/TetO-Cre transgenes
were crossed with each other, with Dox induction from
E10.5. The Ctnnb1fx/fx mice, with floxed exon 2 to exon 6,
were obtained from Jackson Laboratory [37].
Mice with lung mesenchyme-specific constitutively
active Ctnnb1 expression were generated at Justus Liebig
University Giessen, by crossing Tbx4-CreERT2 transgenic
mice and the mice with floxed exon 3 of Ctnnb1
(Ctnnbfx-ex3). Deletion of Ctnnb1 exon 3 was achieved
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(100 mg/kg body weight, Sigma) at E10.5, which resulted
in expression of a constitutively active form of Ctnnb1
[38]. Tbx4-CreERT2 mice, with the same Tbx4 lung en-
hancer as Tbx4-rtTA above, were provided by Dr. Mark
Krasnow at Stanford University, and Ctnnbfx-ex3 mice
were obtained from Dr. Mark Taketo [38].
All mice were bred in C57BL/6 strain background.
The mice used in this study were housed in pathogen-
free facilities. All procedures were approved by the re-
lated Institutional Animal Care and Use Committees.
Histology and immunofluorescence analysis
Morphological analysis was conducted as previously
described [11]. Immunofluorescence staining was per-
formed following the methods published previously [39].
The related antibodies are listed in Additional file 8.
Whole mount E-cadherin immunostaining was used to
visualize lung epithelial branching following a modified
protocol published previously [40]. Fluorescence images
were taken using the Zeiss LSM710 confocal microscope
at the Imaging Core Facility of Children’s Hospital Los
Angeles. Flk1+/PECAM1−, Flk1+/PECAM1+, and DAPI+
cells were counted under 200X magnification using a
Cell Counter plugin of Fiji imaging software (1.48q). Cell
counting was repeated with four mice in each genotype
group.
Cell proliferation, apoptosis, and DNA content analyses
For in vivo cell proliferation assay, pregnant mice were in-
traperitoneally (IP) injected with 5′-ethynyl-2′-deoxyuridine
(EdU, 5 mg/kg body weight, Life Technologies), which is
thymidine analogue incorporated into newly synthesized
DNA. For short-term labeling, EdU was administrated 2
hours before harvesting lung specimens. Incorporated
EdU was detected using Alexa Fluor azide (Life Technolo-
gies), and cell nuclei were counterstained with DAPI. The
image analysis was performed in four random fields per
slide from a total of four slides per mouse by an experi-
enced observer blind to the mouse genotype. The ratios of
EdU-labeled nuclei to total nuclei (n > 300 per field for
mesenchymal cells and n > 50 per field for epithelial cells)
were used to evaluate cell proliferation, and the experi-
ments were repeated in more than three mice within each
genotype group. For pulse-chase experiments, IP injection
of EdU was performed at E11.5, and embryonic mouse
lung specimens were harvested at E13.5. The sizes of cell
nuclei (n > 600 from at least three mouse lungs in each
genotype group) were evaluated by quantifying their
average areas under 630X magnification using Fiji im-
aging software (1.48q). Apoptosis was evaluated using
an ApopTag kit (Trevigen). For analysis of cellular
DNA content, cells from E13.5 lungs were prepared by
tissue digestion, and cellular DNAs were stained with50 μg/ml of propidium iodide (PI). Differences in DNA
content were determined based on fluorescence inten-
sity of PI by FACS. Cells that are in the G0/G1 phase
have a defined amount (1×) of DNA (that is, a diploid
chromosomal DNA), while cells in the G2 and M
phases (G2/M) have a 2× amount of DNA (a tetraploid
chromosomal DNA). Cells containing DNA between 1×
and 2× amounts are in S phase.
Cell culture, real-time PCR, and western blot
Human fetal lung fibroblast cell line (HLF1) was pur-
chased from ATCC. The cultured cells were treated with
BMP4 (50 ng/ml to 100 ng/ml final concentration, R&D
Systems) overnight and then harvested for RNA and
protein analyses.
Total RNA was isolated from cultured cells or lung tis-
sues using the RNeasy Kit (Qiagen). cDNA synthesis and
real-time PCR were performed as described in a previous
publication [36]. The related oligonucleotide primers are
listed in Additional file 9. Protein lysate was prepared from
lung tissues (n = 3 per group) or cultured cells (n = 4 per
group) and analyzed by western blot as previously de-
scribed [41]. The related antibodies used for western blot
are listed in Additional file 8.
Whole mount in situ hybridization
Lungs were isolated from embryos and fixed for 2 hours
in 4 % paraformaldehyde in phosphate buffered saline
(PBS). The samples were washed twice in PBS for 5 min,
transferred to 70 % ethanol overnight, and stored in 100 %
ethanol until needed. Whole mount in situ hybridization
was conducted as previously described, with Fgf10 or
Bmp4 antisense riboprobes transcribed from murine Fgf10
or Bmp4 cDNA templates [42].
Chromatin immunoprecipitation (ChIP)
Three E18.5 WT or Apc CKO lung tissues were pooled,
cross-linked with 1.5 % formaldehyde, and then quenched
using glycine. Chromatin DNAs were then co-precipitated
with the interacted proteins of interest with antibodies
against Histone H3, or active Ctnnb1 (Cell Signaling Tech-
nology). Normal rabbit IgG was used as negative control.
The co-immunoprecipitated DNAs were released and
purified using a SimpleChIP® Plus Enzymatic Chromatin
IP Kit (Cell Signaling Technology) and analyzed by PCR
with the primers listed in Additional file 10. The experi-
ments were repeated three times.
In utero cardiac injection of mouse embryos
Pulmonary vascular perfusion followed the method de-
scribed by Shah [43]. In brief, the pregnant mouse was
anesthetized and subjected to a laparotomy, in which the
uterus was exposed and a single embryo was isolated. The
fetal mice were subjected to thoracotomy. 5.0 μl of FITC-
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containing 1 mg/ml trypan blue was injected to the right
ventricle using a fine glass needle. The injected lectin was
allowed to circulate for 5 min for its binding to the endo-
thelial wall of the vasculature. Then, the embryos were
dissected, fixed with 4 % buffered paraformaldehyde, and
embedded in OCT for tissue frozen section.Statistical analysis
All quantitative data were presented as mean ± s.d. Stat-
istical analyses were performed using Student’s t-tests,
with P ≤ 0.05 considered significant.Additional files
Additional file 1: Accumulation of active Ctnnb1 in E12.5 lung
mesenchymal cells was verified using an alternative anti-
nonphospho-Ctnnb1 (Ser37/Thr41) antibody from Millipore, which
was different from the anti-nonphospho-Ctnnb1 (Ser33/37/Thr41)
antibody (Cell Signaling Technology) used in Fig. 1d.
Additional file 2: Altered lung mesenchymal cell density and
orientation in lung mesenchyme-specific Apc CKO embryos at E12.5
and E13.5.
Additional file 3: Changes in E14.5 Apc CKO mouse lung, shown by
a series of H&E-stained horizontal tissue sections.
Additional file 4: Cell proliferation was compared between E11.5
WT lungs and mesenchyme-specific constitutively active Ctnnb1
lungs by 2-hour EdU labeling. Epithelial tubes were highlighted with
dashed lines.
Additional file 5: Alterations of cellular primary cilia (A) and c-Myc
expression (B) in Apc CKO lung from E11.5 to E12.5 were shown by
immunofluorescence staining using the indicated antibodies. Cell
nuclei were counterstained with DAPI (blue).
Additional file 6: No change in apoptosis was seen in E13.5 Apc
CKO lung compared to WT controls, shown by TUNEL.
Additional file 7: The Tbx4-rtTA-driven Tet-On system with Dox
induction after E10.5 was not able to directly target endothelial cells.
Tbx4-rtTA targeted cells expressed mGFP (green) in the E11.5 Tbx4-rtTA/
TetO-Cre/mT-mG reporter mouse lung with Dox induction from E10.5, while
endothelial cells were detected by PECAM1 or Flk1 immunostaining (red).
Overlap between GFP and endothelial marker was not detected.
Additional file 8: Primary antibodies used for immunochemistry
and western blot.
Additional file 9: DNA primers used for real-time RT-PCR.
Additional file 10: DNA primers used in ChIP assay.Abbreviations
Angpt1: angiopoietin 1; Apc: adenomatous polyposis coli; BMP: bone
morphogenetic protein; ChIP: chromatin co-immunoprecipitation;
CKO: conditional knockout; DAPI: 4′,6-diamidino-2-phenylindole;
Dox: doxycycline; E: embryonic day; EdU: 5-ethynyl-2-deoxyuridine;
FGF: fibroblast growth factor; FITC: fluorescein isothiocyanate; Igf1: insulin-like
growth factor 1; mT-mG: loxP-mTomato-STOP-loxP-mGFP; PECAM1: platelet
endothelial cell adhesion molecule 1; rtTA: reverse tetracycline transactivator;
SMA: α-smooth muscle actin; Vcan: versican; Vegf-a: vascular endothelial
growth factor A; WT: wild type.Competing interests
The authors declare that they have no competing interests.Authors’ contributions
Concept and design: YL, WS; acquisition of data: YL, EEA, GT, HC, JC, BQ;
analysis and interpretation: YL, DW, SB, DBM, WS; drafting and editing of the
manuscript: YL, WS. All authors read and approved the final manuscript.Acknowledgments
We thank Dr. Esteban Fernandez at the Cell Imaging Core of CHLA for
helping with confocal imaging. This research was supported by NIH/NHLBI
grants R21-HL109932 and R01-HL068597 (WS), a California Institute for
Regenerative Medicine Training Grant (YL), The Saban Research Institute of
Children’s Hospital Los Angeles Pilot Project Grant (WS), the DFG grants
BE4443/4-1 and BE4443/6-1 (SB), LOEWE and UKGMC as well as the program
of competitive growth of Kazan Federal University (SB).
Author details
1Saban Research Institute, Children’s Hospital Los Angeles, Los Angeles, CA
90027, USA. 2Department of Surgery, Keck School of Medicine, University of
Southern California, Los Angeles, CA 90027, USA. 3Excellence Cluster
Cardio-Pulmonary System, Justus Liebig University Giessen, 35392 Giessen,
Hessen, Germany. 4Institute of Fundamental Medicine and Biology, Kazan
(Volga Region) Federal University, 420008 Kazan, Russian Federation. 5Spine
Surgery, The Affiliated Drum Tower Hospital of Nanjing University Medical
School, Nanjing 210008, China. 6Department of Genetics, University of
Georgia, Athens, GA 30602, USA.
Received: 12 May 2015 Accepted: 11 June 2015
References
1. Morrisey EE, Hogan BL. Preparing for the first breath: genetic and cellular
mechanisms in lung development. Dev Cell. 2010;18:8–23.
2. de Mello DE, Sawyer D, Galvin N, Reid LM. Early fetal development of lung
vasculature. Am J Respir Cell Mol Biol. 1997;16:568–81.
3. Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, Albertsen H, et al.
Identification and characterization of the familial adenomatous polyposis
coli gene. Cell. 1991;66:589–600.
4. Aoki K, Taketo MM. Adenomatous polyposis coli (APC): a multi-functional
tumor suppressor gene. J Cell Sci. 2007;120:3327–35.
5. Gurbuz AK, Giardiello FM, Petersen GM, Krush AJ, Offerhaus GJ, Booker SV,
et al. Desmoid tumours in familial adenomatous polyposis. Gut.
1994;35:377–81.
6. Ivaniutsin U, Chen Y, Mason JO, Price DJ, Pratt T. Adenomatous polyposis
coli is required for early events in the normal growth and differentiation of
the developing cerebral cortex. Neural Dev. 2009;4:3.
7. Kuraguchi M, Wang XP, Bronson RT, Rothenberg R, Ohene-Baah NY, Lund JJ,
et al. Adenomatous polyposis coli (APC) is required for normal development
of skin and thymus. PLoS Genet. 2006;2:e146.
8. Li A, Chan B, Felix JC, Xing Y, Li M, Brody SL, et al. Tissue-dependent
consequences of Apc inactivation on proliferation and differentiation of
ciliated cell progenitors via Wnt and notch signaling. PLoS One. 2013;8, e62215.
9. Okubo T, Hogan BL. Hyperactive Wnt signaling changes the developmental
potential of embryonic lung endoderm. J Biol. 2004;3:11.
10. Li A, Xing Y, Chan B, Heisterkamp N, Groffen J, Borok Z, et al. Cell
type-specific expression of adenomatous polyposis coli in lung
development, injury, and repair. Dev Dyn. 2010;239:2288–97.
11. Zhang W, Menke DB, Jiang M, Chen H, Warburton D, Turcatel G, et al.
Spatial-temporal targeting of lung-specific mesenchyme by a Tbx4
enhancer. BMC Biol. 2013;11:111.
12. Kobayashi T, Dynlacht BD. Regulating the transition from centriole to basal
body. J Cell Biol. 2011;193:435–44.
13. Plotnikova OV, Pugacheva EN, Golemis EA. Primary cilia and the cell cycle.
Methods Cell Biol. 2009;94:137–60.
14. Lee BY, Han JA, Im JS, Morrone A, Johung K, Goodwin EC, et al.
Senescence-associated beta-galactosidase is lysosomal beta-galactosidase.
Aging Cell. 2006;5:187–95.
15. Rufini A, Tucci P, Celardo I, Melino G. Senescence and aging: the critical
roles of p53. Oncogene. 2013;32:5129–43.
16. Shu W, Guttentag S, Wang Z, Andl T, Ballard P, Lu MM, et al. Wnt/beta-catenin
signaling acts upstream of N-myc, BMP4, and FGF signaling to regulate
proximal-distal patterning in the lung. Dev Biol. 2005;283:226–39.
Luo et al. BMC Biology  (2015) 13:42 Page 19 of 1917. Yamaguchi TP, Dumont DJ, Conlon RA, Breitman ML, Rossant J. flk-1, an
flt-related receptor tyrosine kinase is an early marker for endothelial cell
precursors. Development. 1993;118:489–98.
18. Yang J, Zhang W, Evans PM, Chen X, He X, Liu C. Adenomatous polyposis
coli (APC) differentially regulates beta-catenin phosphorylation and
ubiquitination in colon cancer cells. J Biol Chem. 2006;281:17751–7.
19. Niehrs C, Acebron SP. Mitotic and mitogenic Wnt signalling. EMBO J.
2012;31:2705–13.
20. Yin Y, White AC, Huh SH, Hilton MJ, Kanazawa H, Long F, et al. An FGF-WNT
gene regulatory network controls lung mesenchyme development. Dev Biol.
2008;319:426–36.
21. Fodde R, Smits R, Clevers H. APC, signal transduction and genetic instability
in colorectal cancer. Nat Rev Cancer. 2001;1:55–67.
22. Carraro G, Shrestha A, Rostkovius J, Contreras A, Chao CM, El Agha E, et al.
miR-142-3p balances proliferation and differentiation of mesenchymal cells
during lung development. Development. 2014;141:1272–81.
23. Rockich BE, Hrycaj SM, Shih HP, Nagy MS, Ferguson MA, Kopp JL, et al. Sox9
plays multiple roles in the lung epithelium during branching
morphogenesis. Proc Natl Acad Sci U S A. 2013;110:e4456–64.
24. Wight TN. Versican: a versatile extracellular matrix proteoglycan in cell
biology. Curr Opin Cell Biol. 2002;14:617–23.
25. Yang Y, Li Y, Wang Y, Wu J, Yang G, Yang T, et al. Versican gene: regulation
by the β-catenin signaling pathway plays a significant role in dermal papilla
cell aggregative growth. J Dermatol Sci. 2012;68:157–63.
26. Landolt RM, Vaughan L, Winterhalter KH, Zimmermann DR. Versican is
selectively expressed in embryonic tissues that act as barriers to neural crest
cell migration and axon outgrowth. Development. 1995;121:2303–12.
27. Weaver M, Dunn NR, Hogan BL. Bmp4 and Fgf10 play opposing roles
during lung bud morphogenesis. Development. 2000;127:2695–704.
28. Peng T, Tian Y, Boogerd CJ, Lu MM, Kadzik RS, Stewart KM, et al.
Coordination of heart and lung co-development by a multipotent
cardiopulmonary progenitor. Nature. 2013;500:589–92.
29. Galambos C. deMello DE. Molecular mechanisms of pulmonary vascular
development. Pediatr Dev Pathol. 2007;10:1–17.
30. Jiang M, Ku WY, Fu J, Offermanns S, Hsu W, Que J. Gpr177 regulates
pulmonary vasculature development. Development. 2013;140:3589–94.
31. Cornett B, Snowball J, Varisco BM, Lang R, Whitsett J, Sinner D. Wntless is
required for peripheral lung differentiation and pulmonary vascular
development. Dev Biol. 2013;379:38–52.
32. Han RN, Post M, Tanswell AK, Lye SJ. Insulin-like growth factor-I receptor-
mediated vasculogenesis/angiogenesis in human lung development.
Am J Respir Cell Mol Biol. 2003;28:159–69.
33. Folkman J, D’Amore PA. Blood vessel formation: what is its molecular basis?
Cell. 1996;87:1153–5.
34. Suri C, McClain J, Thurston G, McDonald DM, Zhou H, Oldmixon EH, et al.
Increased vascularization in mice overexpressing angiopoietin-1. Science.
1998;282:468–71.
35. Muzumdar MD, Tasic B, Miyamichi K, Li L, Luo L. A global double-
fluorescent Cre reporter mouse. Genesis. 2007;45:593–605.
36. Sun J, Chen H, Chen C, Whitsett JA, Mishina Y, Bringas P, et al. Prenatal lung
epithelial cell-specific abrogation of Alk3-bone morphogenetic protein
signaling causes neonatal respiratory distress by disrupting distal airway
formation. Am J Pathol. 2008;172:571–82.
37. Brault V, Moore R, Kutsch S, Ishibashi M, Rowitch DH, McMahon AP, et al.
Inactivation of the beta-catenin gene by Wnt1-Cre-mediated deletion results
in dramatic brain malformation and failure of craniofacial development.
Development. 2001;128:1253–64.
38. Harada N, Tamai Y, Ishikawa T, Sauer B, Takaku K, Oshima M, et al. Intestinal
polyposis in mice with a dominant stable mutation of the beta-catenin
gene. EMBO J. 1999;18:5931–42.
39. Xu B, Chen C, Chen H, Zheng SG, Bringas Jr P, Xu M, et al. Smad1 and its
target gene Wif1 coordinate BMP and Wnt signaling activities to regulate
fetal lung development. Development. 2011;138:925–35.
40. Metzger RJ, Klein OD, Martin GR, Krasnow MA. The branching programme
of mouse lung development. Nature. 2008;453:745–50.
41. Chen H, Sun J, Buckley S, Chen C, Warburton D, Wang XF, et al. Abnormal
mouse lung alveolarization caused by Smad3 deficiency is a developmental
antecedent of centrilobular emphysema. Am J Physiol Lung Cell Mol
Physiol. 2005;288:L683–91.42. Turcatel G, Rubin N, Menke DB, Martin G, Shi W, Warburton D. Lung
mesenchymal expression of Sox9 plays a critical role in tracheal
development. BMC Biol. 2013;11:117.
43. Shah SR, Esni F, Jakub A, Paredes J, Lath N, Malek M, et al. Embryonic
mouse blood flow and oxygen correlate with early pancreatic
differentiation. Dev Biol. 2011;349:342–9.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
